Qilu Pharmaceutical (Hainan) Co., Ltd.

7 clinical trials · Sponsor

Record	Firm	Date
A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS) (NCT07138833)	Qilu Pharmaceutical (Hainan) Co., Ltd.	2025-09-01
A Study of QLM2011 in Subjects With Advanced Solid Tumors (NCT06925659)	Qilu Pharmaceutical (Hainan) Co., Ltd.	2025-05-01
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus (NCT06446310)	Qilu Pharmaceutical (Hainan) Co., Ltd.	2024-06-18
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting (NCT06932107)	Qilu Pharmaceutical (Hainan) Co., Ltd.	2024-02-02
a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency (NCT05922436)	Qilu Pharmaceutical (Hainan) Co., Ltd.	2023-07-15
A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV. (NCT05822713)	Qilu Pharmaceutical (Hainan) Co., Ltd.	2023-04-29
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain (NCT05648669)	Qilu Pharmaceutical (Hainan) Co., Ltd.	2022-09-04

Every clearance here is in the API, with alerts when new ones post.